Zenith clinical research

Hollywood, Florida 33024

3 studies enrolling now · 9 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease, Knee Osteoarthritis (OA), Lipoprotein Disorder, Lung Cancer, Obesity, Overweight, Primary Prevention of Atherosclerotic Cardiovascular Disease, Weight Change Trajectory, Weight Change, Body

Studies at this site

• Pelacarsen Roll-over Extension Program — Recruiting now
• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity — Recruiting now
• A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain — Recruiting now
• A Study of DII235 in Adults With Elevated Lipoprotein(a) — Running, not enrolling
• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
• Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease — Running, not enrolling
• Screening for High Frequency Malignant Disease — Running, not enrolling
• Lp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVD — Completed
• Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on Tirzepatide — Running, not enrolling